METTL14 and neoplasm: Moreover, Li et al. further elucidate that knocking down METTL14 and NSUN2 in OS cells can respectively potentiate the inhibitory effects of ATRA and doxorubicin on tumors, thereby suppressing tumor drug resistance 11, 132.